Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR)
SAR 31.65
(-0.32%)
SAR 31.65
(-0.32%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.65 Billion SAR | 15.89% |
| 2022 | 1.42 Billion SAR | -2.29% |
| 2021 | 1.45 Billion SAR | -6.39% |
| 2020 | 1.55 Billion SAR | 0.45% |
| 2019 | 1.55 Billion SAR | 21.78% |
| 2018 | 1.27 Billion SAR | -8.02% |
| 2017 | 1.38 Billion SAR | -24.72% |
| 2016 | 1.84 Billion SAR | 7.98% |
| 2015 | 1.7 Billion SAR | 15.98% |
| 2014 | 1.47 Billion SAR | 13.39% |
| 2013 | 1.29 Billion SAR | 4.15% |
| 2012 | 1.24 Billion SAR | 10.24% |
| 2011 | 1.12 Billion SAR | 8.83% |
| 2010 | 1.03 Billion SAR | 9.14% |
| 2009 | 950.74 Million SAR | 9.04% |
| 2008 | 871.93 Million SAR | 9.3% |
| 2007 | 797.74 Million SAR | 9.61% |
| 2006 | 727.83 Million SAR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 475 Million SAR | 43.5% |
| 2024 Q2 | 373.37 Million SAR | -21.39% |
| 2023 Q3 | 381.62 Million SAR | -6.63% |
| 2023 Q1 | 532.1 Million SAR | 44.06% |
| 2023 FY | 1.65 Billion SAR | 15.89% |
| 2023 Q2 | 408.72 Million SAR | -23.19% |
| 2023 Q4 | 331 Million SAR | -13.26% |
| 2022 FY | 1.42 Billion SAR | -2.29% |
| 2022 Q4 | 369.36 Million SAR | 3.46% |
| 2022 Q3 | 357.02 Million SAR | 14.94% |
| 2022 Q1 | 451.27 Million SAR | 23.49% |
| 2022 Q2 | 310.62 Million SAR | -31.17% |
| 2021 Q4 | 365.44 Million SAR | 17.12% |
| 2021 Q2 | 326.68 Million SAR | -28.3% |
| 2021 FY | 1.45 Billion SAR | -6.39% |
| 2021 Q3 | 312.01 Million SAR | -4.49% |
| 2021 Q1 | 455.64 Million SAR | 23.55% |
| 2020 Q1 | 202.39 Million SAR | -67.13% |
| 2020 Q3 | 378.97 Million SAR | 136.16% |
| 2020 FY | 1.55 Billion SAR | 0.45% |
| 2020 Q4 | 368.79 Million SAR | -2.69% |
| 2020 Q2 | 160.47 Million SAR | -20.71% |
| 2019 Q2 | 300.52 Million SAR | -15.6% |
| 2019 FY | 1.55 Billion SAR | 21.78% |
| 2019 Q3 | 280.21 Million SAR | -6.76% |
| 2019 Q4 | 615.7 Million SAR | 119.73% |
| 2019 Q1 | 356.07 Million SAR | -0.42% |
| 2018 Q3 | 213.69 Million SAR | -31.67% |
| 2018 Q1 | 390.79 Million SAR | -4.87% |
| 2018 FY | 1.27 Billion SAR | -8.02% |
| 2018 Q4 | 357.58 Million SAR | 67.33% |
| 2018 Q2 | 312.73 Million SAR | -19.97% |
| 2017 Q2 | 304.63 Million SAR | -22.51% |
| 2017 FY | 1.38 Billion SAR | -24.72% |
| 2017 Q3 | 277.6 Million SAR | -8.87% |
| 2017 Q1 | 393.1 Million SAR | -14.2% |
| 2017 Q4 | 410.78 Million SAR | 47.97% |
| 2016 Q3 | 375.2 Million SAR | -24.34% |
| 2016 Q1 | 511.9 Million SAR | -3.19% |
| 2016 FY | 1.84 Billion SAR | 7.98% |
| 2016 Q2 | 495.93 Million SAR | -3.12% |
| 2016 Q4 | 458.14 Million SAR | 22.11% |
| 2015 Q2 | 435.8 Million SAR | 0.83% |
| 2015 Q1 | 432.19 Million SAR | 1.02% |
| 2015 Q3 | 308.26 Million SAR | -29.26% |
| 2015 FY | 1.7 Billion SAR | 15.98% |
| 2015 Q4 | 528.78 Million SAR | 71.53% |
| 2014 Q4 | 427.81 Million SAR | 60.82% |
| 2014 Q3 | 266.01 Million SAR | -28.9% |
| 2014 Q2 | 374.13 Million SAR | -6.98% |
| 2014 Q1 | 402.21 Million SAR | 6.87% |
| 2014 FY | 1.47 Billion SAR | 13.39% |
| 2013 Q1 | 361.37 Million SAR | -15.51% |
| 2013 Q3 | 219.13 Million SAR | -36.34% |
| 2013 Q4 | 376.34 Million SAR | 71.75% |
| 2013 FY | 1.29 Billion SAR | 4.15% |
| 2013 Q2 | 344.21 Million SAR | -4.75% |
| 2012 Q4 | 427.72 Million SAR | 88.09% |
| 2012 FY | 1.24 Billion SAR | 10.24% |
| 2012 Q3 | 227.39 Million SAR | 0.0% |
| 2011 FY | 1.12 Billion SAR | 8.83% |
| 2010 FY | 1.03 Billion SAR | 9.14% |
| 2009 FY | 950.74 Million SAR | 9.04% |
| 2008 FY | 871.93 Million SAR | 9.3% |
| 2007 FY | 797.74 Million SAR | 9.61% |
| 2006 FY | 727.83 Million SAR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Jamjoom Pharmaceuticals Factory Company | 1.1 Billion SAR | -50.169% |